Friday, October 21, 2016
Phase 1 Minimize


  • Share information on proposed or new legislation and regulation that impacts the pharmaceutical supply chain
  • Share information on counterfeits, cargo thefts and adulterated product in the pharmaceutical supply chain
  • Develop voluntary standards for the quality and authenticity of supplies and suppliers.Develop and implement audit standards and audit training and certification programs.
  • Create or obtain the infrastructure necessary to share data regarding quality and authenticity of supplies and suppliers that could adversely impact patient health or welfare.


Phase 2 Minimize
  • Begin independent and shared audits.
  • Determine if a full time audit committee is required.
  • Implement additional standards for:
  • Right Size Testing
  • Pedigree
  • Supplier Site & Distribution
  • Channel Certification
  • Reporting of and Responding to
  • Suspicious Events

Phase 3 Minimize
  • Fund the further development of new technologies for securing the supply chain and detecting adulteration in the supply chain.


2009 © Rx-360